4-hydroxynonenal causes impairment of human subcutaneous adipogenesis and induction of adipocyte insulin resistance.
Level 5 - mechanism / opinion, no new human data
In vitro laboratory study using human tissue samples (bench research)
PubMed 28088621 · doi:10.1016/j.freeradbiomed.2017.01.015
What was done
Subcutaneous adipose tissue samples were obtained from 18 obese premenopausal women categorized as insulin sensitive or insulin resistant undergoing bariatric surgery. Researchers evaluated 4-hydroxynonenal (4-HNE) protein adduct distribution by immunohistochemistry and tested the effects of short- and long-term in vitro 4-HNE exposure on oxidative stress markers, cell growth, adipogenic differentiation, and insulin signaling (IRS-1, p70S6K, GSK3α/β, and BAD) in preadipocytes isolated from both donor groups.
What was found
The abstract reports no numerical values or statistical effect sizes. Qualitatively, 4-HNE protein adducts localized primarily to adipocytes and vascular structures. In vitro 4-HNE treatment suppressed preadipocyte proliferation, increased reactive oxygen species and antioxidant enzymes, and caused a larger reduction in adipogenesis in cells from insulin-sensitive compared to insulin-resistant donors. 4-HNE also induced dephosphorylation of IRS-1 and p70S6K while activating GSK3α/β and BAD.
Why it matters
This study provides mechanistic evidence that the lipid peroxidation byproduct 4-HNE directly inhibits preadipocyte development and triggers cellular insulin resistance in human subcutaneous fat.
Limits
The study is restricted to in vitro cell models from a small cohort of 18 premenopausal obese women, limiting direct translation to in vivo conditions, males, or non-obese individuals. Exact quantitative measurements and statistical estimates are omitted from the abstract.
Cited by
- supports 4-HNE, a peroxidation metabolite of linoleic acid, inhibits the hyperplasia potential of fat cells and forces hypertrophic fat growth.